Skip to main content
. 2022 Feb 23;12:3074. doi: 10.1038/s41598-022-05164-4

Figure 3.

Figure 3

Effects of miR-298 on endogenous APP and BACE1 levels in human astrocyte cells. (a,b) Scale drawings of endogenous APP and BACE1 mRNA undefined 3′-UTR with miR-298 binding sites. With full-length 3′-UTR, where miRNAs can bind, miR-298 can reduce APP and BACE1 expression levels. (c,d) Densitometric analysis of APP and BACE1 levels. Each symbol represents a different statistical group. (e) Cell viability determined by CTG assay. (f) Western blotting of APP, BACE1 and β-actin. Results of pairwise comparison of all treatments is shown by symbols. Treatments sharing a symbol did not significantly differ (p < 0.05). "(ns)" indicates no significant pairwise differences.